Yulug I - Search Results

1

p53 polymorphism influences response in cancer chemotherapy via modulation of p73-dependent apoptosis.

Bergamaschi D, Gasco M, Hiller L, Sullivan A, Syed N, Trigiante G, Yulug I, Merlano M, Numico G, Comino A, Attard M, Reelfs O, Gusterson B, Bell AK, Heath V, Tavassoli M, Farrell PJ, Smith P, Lu X, Crook T. Bergamaschi D, et al. Among authors: yulug i. Cancer Cell. 2003 Apr;3(4):387-402. doi: 10.1016/s1535-6108(03)00079-5. Cancer Cell. 2003. PMID: 12726864 Free article.

2

Concomitant inactivation of p53 and Chk2 in breast cancer.

Sullivan A, Yuille M, Repellin C, Reddy A, Reelfs O, Bell A, Dunne B, Gusterson BA, Osin P, Farrell PJ, Yulug I, Evans A, Ozcelik T, Gasco M, Crook T. Sullivan A, et al. Among authors: yulug i. Oncogene. 2002 Feb 21;21(9):1316-24. doi: 10.1038/sj.onc.1205207. Oncogene. 2002. PMID: 11857075

3

Epigenetic inactivation of 14-3-3 sigma in oral carcinoma: association with p16(INK4a) silencing and human papillomavirus negativity.

Gasco M, Bell AK, Heath V, Sullivan A, Smith P, Hiller L, Yulug I, Numico G, Merlano M, Farrell PJ, Tavassoli M, Gusterson B, Crook T. Gasco M, et al. Among authors: yulug i. Cancer Res. 2002 Apr 1;62(7):2072-6. Cancer Res. 2002. PMID: 11929827

4

A common polymorphism acts as an intragenic modifier of mutant p53 behaviour.

Marin MC, Jost CA, Brooks LA, Irwin MS, O'Nions J, Tidy JA, James N, McGregor JM, Harwood CA, Yulug IG, Vousden KH, Allday MJ, Gusterson B, Ikawa S, Hinds PW, Crook T, Kaelin WG Jr. Marin MC, et al. Among authors: yulug ig. Nat Genet. 2000 May;25(1):47-54. doi: 10.1038/75586. Nat Genet. 2000. PMID: 10802655

5

TP53 mutations in familial breast cancer: functional aspects.

Gasco M, Yulug IG, Crook T. Gasco M, et al. Hum Mutat. 2003 Mar;21(3):301-6. doi: 10.1002/humu.10173. Hum Mutat. 2003. PMID: 12619116 Review.

6

Identification of genes induced by BRCA1 in breast cancer cells.

Atalay A, Crook T, Ozturk M, Yulug IG. Atalay A, et al. Biochem Biophys Res Commun. 2002 Dec 20;299(5):839-46. doi: 10.1016/s0006-291x(02)02751-1. Biochem Biophys Res Commun. 2002. PMID: 12470655

7

p53 mutation with frequent novel condons but not a mutator phenotype in BRCA1- and BRCA2-associated breast tumours.

Crook T, Brooks LA, Crossland S, Osin P, Barker KT, Waller J, Philp E, Smith PD, Yulug I, Peto J, Parker G, Allday MJ, Crompton MR, Gusterson BA. Crook T, et al. Among authors: yulug i. Oncogene. 1998 Oct 1;17(13):1681-9. doi: 10.1038/sj.onc.1202106. Oncogene. 1998. PMID: 9796697

8

Gene expression in response to retinoic acid in novel human chromosome 21 monochromosomal cell hybrids.

Yulug IG, Killary AM, Sandhu AK, Athwal RS, Fox M, Fisher EM. Yulug IG, et al. Somat Cell Mol Genet. 1995 Sep;21(5):357-65. doi: 10.1007/BF02257471. Somat Cell Mol Genet. 1995. PMID: 8619133

9

Lack of association between the MDM2-SNP309 polymorphism and breast cancer risk.

Petenkaya A, Bozkurt B, Akilli-Ozturk O, Kaya HS, Gur-Dedeoglu B, Yulug IG. Petenkaya A, et al. Among authors: yulug ig. Anticancer Res. 2006 Nov-Dec;26(6C):4975-7. Anticancer Res. 2006. PMID: 17214373 Free article.

10

A human SHC-related sequence maps to chromosome 17, the SHC gene maps to chromosome 1.

Yulug IG, Egan SE, See CG, Fisher EM. Yulug IG, et al. Hum Genet. 1995 Aug;96(2):245-8. doi: 10.1007/BF00207393. Hum Genet. 1995. PMID: 7635484

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

31 results

Search Page